These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2875927)
1. Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. The Copenhagen Study Group for Liver Diseases. Hepatology; 1986; 6(5):807-13. PubMed ID: 2875927 [TBL] [Abstract][Full Text] [Related]
2. No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis. Gluud C; Christoffersen P; Eriksen J; Wantzin P; Knudsen BB Am J Gastroenterol; 1987 Jul; 82(7):660-4. PubMed ID: 3300274 [TBL] [Abstract][Full Text] [Related]
3. Testosterone and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies in men. Gluud C Dan Med Bull; 1988 Dec; 35(6):564-75. PubMed ID: 3064977 [TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice. Pelletier G; Roulot D; Davion T; Masliah C; Causse X; Oberti F; Raabe JJ; Van Lemmens C; Labadie H; Serfaty L; Hepatology; 2003 Apr; 37(4):887-92. PubMed ID: 12668982 [TBL] [Abstract][Full Text] [Related]
5. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study. Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542 [TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial. Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131 [TBL] [Abstract][Full Text] [Related]
7. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial]. Yin SS; Wang BE; Wang TL; Jia JD; Qian LX Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205 [TBL] [Abstract][Full Text] [Related]
8. Colchicine in the treatment of cirrhosis of the liver. Kershenobich D; Vargas F; Garcia-Tsao G; Perez Tamayo R; Gent M; Rojkind M N Engl J Med; 1988 Jun; 318(26):1709-13. PubMed ID: 3287167 [TBL] [Abstract][Full Text] [Related]
9. Treatment of cirrhosis with colchicine. A double-blind randomized trial. Kershenobich D; Uribe M; Suárez GI; Mata JM; Pérez-Tamayo R; Rojkind M Gastroenterology; 1979 Sep; 77(3):532-6. PubMed ID: 378754 [TBL] [Abstract][Full Text] [Related]
10. Effect of treatment with paromomycin on endotoxemia in patients with alcoholic liver disease--a double-blind, placebo-controlled trial. Bode C; Schäfer C; Fukui H; Bode JC Alcohol Clin Exp Res; 1997 Nov; 21(8):1367-73. PubMed ID: 9394106 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study. Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial. Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study. Homoncik M; Jilma-Stohlawetz P; Schmid M; Ferlitsch A; Peck-Radosavljevic M Aliment Pharmacol Ther; 2004 Aug; 20(4):437-43. PubMed ID: 15298638 [TBL] [Abstract][Full Text] [Related]
15. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Peniston JH; Gould E Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907 [TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Bell H; Jahnsen J; Kittang E; Raknerud N; Sandvik L Scand J Gastroenterol; 2004 Sep; 39(9):858-63. PubMed ID: 15513384 [TBL] [Abstract][Full Text] [Related]
17. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial. Ogrendik M Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134 [TBL] [Abstract][Full Text] [Related]
19. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial. Seidman SN; Orr G; Raviv G; Levi R; Roose SP; Kravitz E; Amiaz R; Weiser M J Clin Psychopharmacol; 2009 Jun; 29(3):216-21. PubMed ID: 19440073 [TBL] [Abstract][Full Text] [Related]
20. Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study. Safarinejad MR J Diabetes Complications; 2004; 18(4):205-10. PubMed ID: 15207837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]